Czech National Bank Has $12.29 Million Stock Position in Ventas, Inc. $VTR

Czech National Bank boosted its position in shares of Ventas, Inc. (NYSE:VTRFree Report) by 7.0% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 138,383 shares of the real estate investment trust’s stock after buying an additional 9,028 shares during the quarter. Czech National Bank’s holdings in Ventas were worth $12,288,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. NewEdge Advisors LLC grew its position in shares of Ventas by 856.1% during the 1st quarter. NewEdge Advisors LLC now owns 7,926 shares of the real estate investment trust’s stock worth $545,000 after buying an additional 7,097 shares during the period. Empowered Funds LLC lifted its holdings in Ventas by 6.8% in the first quarter. Empowered Funds LLC now owns 8,373 shares of the real estate investment trust’s stock valued at $576,000 after buying an additional 536 shares during the period. Woodline Partners LP lifted its holdings in Ventas by 46.8% in the first quarter. Woodline Partners LP now owns 36,826 shares of the real estate investment trust’s stock valued at $2,532,000 after buying an additional 11,739 shares during the period. Focus Partners Wealth boosted its stake in Ventas by 130.4% in the first quarter. Focus Partners Wealth now owns 21,613 shares of the real estate investment trust’s stock valued at $1,486,000 after acquiring an additional 12,233 shares during the last quarter. Finally, Gamco Investors INC. ET AL bought a new position in Ventas in the second quarter valued at approximately $805,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Ventas

In related news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director owned 28,349 shares of the company’s stock, valued at approximately $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. 0.53% of the stock is owned by insiders.

Wall Street Analyst Weigh In

VTR has been the subject of several recent research reports. Citigroup upped their target price on shares of Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday. Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $100.00 price target on shares of Ventas in a research report on Tuesday, June 16th. Barclays started coverage on Ventas in a research note on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective for the company. UBS Group upped their price objective on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a report on Monday, May 4th. Finally, The Goldman Sachs Group reissued a “buy” rating and issued a $110.00 target price on shares of Ventas in a research note on Tuesday, May 19th. Fifteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus target price of $97.56.

Get Our Latest Research Report on Ventas

Ventas Stock Up 1.1%

Ventas stock opened at $93.31 on Friday. The firm has a market capitalization of $47.87 billion, a price-to-earnings ratio of 172.81, a PEG ratio of 2.15 and a beta of 0.69. The company’s 50 day simple moving average is $89.49 and its 200 day simple moving average is $86.10. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60.

Ventas Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is currently 385.19%.

Ventas Company Profile

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

See Also

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTRFree Report).

Institutional Ownership by Quarter for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.